{"SPADE_UN_26799": {"Sequence Information": {"Peptide Name": "TM9", "Sequence": "XXXXXXX", "Sequence Length": 7, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anti-Mammalian Cell", "Antibiofilm"], "Binding Target": "1. Lipid Bilayer\n2. Virus replication\n3. Sgp", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Self-Assembly of Antimicrobial Peptoids Impacts Their Biological Effects on ESKAPE Bacterial Pathogens.", "Pubmed ID": "35175731", "Reference": "ACS Infect Dis. 2022;8:533-545", "Author": "Nielsen JE, Alford MA, Yung DBY, Molchanova N, Fortkort JA, Lin JS, Diamond G, Hancock REW, Jenssen H, Pletzer D, Lund R, Barron AE", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/35175731"}, {"Title": "Potent Antiviral Activity against HSV-1 and SARS-CoV-2 by Antimicrobial Peptoids.", "Pubmed ID": "33807248", "Reference": "Pharmaceuticals (Basel). 2021;14:304", "Author": "Diamond G, Molchanova N, Herlan C, Fortkort JA, Lin JS, Figgins E, Bopp N, Ryan LK", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/33807248"}], "SPADE ID": "SPADE_UN_26799", "Similar Sequences": [], "Hemolytic Activity": "", "Target Organism": "Enterococcus faecium(MIC=3.13µg/ml),Staphylococcus aureus USA 300 LAC(MIC=1.56µg/ml),Klebsiella pneumoniae KPLN649(MIC=50µg/ml),Acinetobacter baumannii AB5075(MIC=6.25µg/ml),Pseudomonas aeruginosa LESB58(MIC=12.5µg/ml),Enterobacter cloacae 218R1(MIC=12.5µg/ml),SARS-CoV-2(IC50 I=7µg/ml),HSV-1(90-100% REP=20µg/ml)"}}}